Clinical Trial Update: Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SPH3127 in mild-to-moderate ulcerative colitis was terminated, with results posted on ClinicalTrials.gov on 2025-06-26.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SPH3127

Snippet

Sponsor: Shanghai Pharma Biotherapeutics USA Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED | Results posted: 2025-06-26